Showing 1 - 14 results of 14 for search 'M D Levin', query time: 0.07s
Refine Results
-
1
SPHINCTER OCHSNER DYSKINESIA AS A CAUSE OF SUPERIOR MESENTERIC ARTERY SYNDROME by M. D. Levin
Published 2016-05-01
Article -
2
Descending perineum syndrome in children: Pathophysiology and diagnosis by M. D. Levin
Published 2016-03-01
Article -
3
Schatzki ring as a symptom of gastroesophageal reflux disease by M. D. Levin, G. Mendel'son
Published 2016-02-01
Article -
4
Duodenal motor function in health and some diseases: A hypothesis by M D Levin, Z Korshun, G Mendelson
Published 2016-04-01
Article -
5
Postpartum microangiopathic disorders: A case report and review of the literature by C.H. Wessel, C.E. Andreescu, S. Rombout-De Weerd, M.D. Levin
Published 2014-07-01
Article -
6
-
7
PB1886: LONG-TERM TRENDS IN THE LOSS OF LIFE EXPECTANCY AFTER A DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2018 by L. Van Der Straten, C. C. Maas, M.-D. Levin, O. Visser, E. F. Posthuma, J. K. Doorduin, A. W. Langerak, A. P. Kater, A. G. Dinmohamed
Published 2022-06-01
Article -
8
P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAP... by A. Spencer, P. Moreau, M.-V. Mateos, H. Goldschmidt, K. Suzuki, M.-D. Levin, P. Sonneveld, S.-S. Yoon, S. Z. Usmani, K. Weisel, D. Reece, T. Ahmadi, H. Pei, W. Garvin Mayo, X. Gai, J. Carey, R. Carson, M. A. Dimopoulos
Published 2022-06-01
Article -
9
P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10-4 THROUGH IGHV LEADER-BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA by P. Hengeveld, M. van der Klift, P. M. Kolijn, F. Davi, F. Kavelaars, E. de Jonge, S. Robrecht, J. Assmann, L. van der Straten, M. Ritgen, P. Westerweel, K. Fischer, V. Goede, M. Hallek, M.-D. Levin, A. Langerak
Published 2022-06-01
Article -
10
Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia by P. J. Hengeveld, J. Schilperoord-Vermeulen, M. Y. van der Klift, J. M. N. Dubois, P. M. Kolijn, F. G. Kavelaars, M. Rijken, J. A. Dobber, K. Nasserinejad, S. Kersting, P. E. Westerweel, A. P. Kater, A. W. Langerak, M-D. Levin
Published 2023-07-01
Article -
11
P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110 by P. Hengeveld, Y. E. Ertem, J. Dubois, C. Mellink, A.-M. van der Kevie-Kersemaekers, L. Evers, K. Heezen, P. M. Kolijn, O. Mook, M. M. Motazacker, K. Nasserinejad, S. Kersting, P. Westerweel, C. Niemann, A. Kater, A. Langerak, M.-D. Levin
Published 2022-06-01
Article -
12
P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESUL... by K. Groen, M. R. Seefat, B. van der Holt, F. H. Schjesvold, C. A. Stege, M.-D. Levin, M. Hansson, R. B. Leys, J. Regelink, A. Waage, D. Szatkowski, P. Axelsson, T. H. Do, A. Svirskaite, E. van der Spek, E. Haukas, D. Knut-Bojanowska, P. F. Ypma, C. Blimark, U.-H. Mellqvist, N. W. van de Donk, P. Sonneveld, A. Klostergaard, A. J. Vangsted, N. Abdilgaard, S. Zweegman
Published 2022-06-01
Article -
13
P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 14... by K. Groen, M. Seefat, K. Nasserinejad, C. A. Stege, E. van der Spek, Y. M. Bilgin, A. Kentos, M. Sohne, R. J. van Kampen, I. Ludwig, N. Thielen, N. Durdu-Rayman, N. C. de Graauw, N. W. van de Donk, E. G. de Waal, M.-C. Vekemans, G. J. Timmers, M. van der Klift, S. Soechit, P. A. Geerts, M. H. Silbermann, M. Oosterveld, I. Nijhof, P. Sonneveld, S. K. Klein, M.-D. Levin, S. Zweegman
Published 2022-06-01
Article -
14
P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV) by M.R. Seefat, C.A.M. Stege, G.J. Timmers, M.D. Levin, M. Hoogendoorn, P.F. Ypma, I.S. Nijhof, G.A. Velders, L. Strobbe, N. Durdu-Rayman, M. Westerman, M.A. Davidis-van Schoonhoven, R.J.W. van Kampen, A. Beeker, A. Koster, A.C. Dijk, N.W.C.J. van de Donk, E. van der Spek, M.B.L. Leys, M.H. Silbermann, K. Groen, N.C.H.P. van der Burg-de Graauw, H.A.M. Sinnige, K.G. van der Hem, T.H. Levenga, Y.M. Bilgin, P. Sonneveld, S.K. Klein, K. Nasserinejad, H.M. Blommestein, D.G.J. Cucchi, B.I. Lissenberg-Witte, S. Zweegman
Published 2023-05-01
Article